1. Homepage
  2. Equities
  3. Canada
  4. CANADIAN NATIONAL STOCK EXCHANGE
  5. Wesana Health Holdings Inc.
  6. News
  7. Most relevant
    WESA   CA95081C1059

WESANA HEALTH HOLDINGS INC.

(WESA)
  Report
Delayed CANADIAN NATIONAL STOCK EXCHANGE  -  09:36 2022-06-27 am EDT
0.2100 CAD   +5.00%
06/08WESANA HEALTH CEO DANIEL CARCILLO TO KEYNOTE CHARLES RIVER SYMPOSIUM : Re-Imagining Substance Abuse, Addiction, and Mental Health Disorders with Psychedelic Therapies
AQ
05/31Wesana Announces First Quarter 2022 Financial Results
AQ
05/31Wesana Health Holdings Inc. Announces Resignation of Chad Bronstein as Executive Chairman
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about WESANA HEALTH HOLDINGS INC.
06/08WESANA HEALTH CEO DANIEL CARCILLO TO : Re-Imagining Substance Abuse, Addiction, and Mental..
AQ
05/31Wesana Announces First Quarter 2022 Financial Results
AQ
05/31Wesana Health Holdings Inc. Announces Resignation of Chad Bronstein as Executive Chairm..
CI
05/30Wesana Health Holdings Inc. Reports Earnings Results for the First Quarter Ended March ..
CI
05/10Wesana Health Outlines Accelerated Drug Development Pathway
AQ
05/10Wesana Health Holdings Outlines Accelerated Drug Development Pathway
CI
05/05Wesana Announces Singular Focus on Drug Development Prompting a Strategic Review of its..
AQ
05/05Wesana Health Holdings Announces Review of Strategic Alternatives of its Clinics and Ot..
CI
05/02Wesana Health Reports Q4 2021 Financial Results and Provides Subsequent Period Highligh..
AQ
05/02Wesana Health Holdings Inc. Reports Earnings Results for the Full Year Ended December 3..
CI
04/27Wesana Health to Present Live at KCSA Virtual Investor Conference April 28th
AQ
04/19Wesana Is Exploring Broadening SANA-013 Lead Indication to Treat Major Depressive Disor..
AQ
04/18Wesana Explores Broadening SANA-013 Lead Indication to Treat Major Depressive Disorder
CI
04/18Wesana Health Holdings Inc. announced that it expects to receive CAD 3.7854 million in ..
CI
03/29Wesana Health CEO Daniel Carcillo to Speak at Several Leading Investor and Industry Eve..
AQ
03/23Wesana Health Announces New Findings Indicating Psilocybin Potentiates Impact of an Ant..
AQ
03/22Wesana Health Announces New Findings Indicating Psylocibin Potentiates Impact of an Ant..
AQ
03/14Wesana Health Up 25% As Announces Positive Feedback From Pre-IND Meeting With FDA on SA..
MT
03/14WESANA HEALTH BRIEF : Up Near 25% As Announces Positive Feedback From Pre-IND Meeting With..
MT
03/14Wesana Health Announces Positive Feedback From Pre-IND Meeting With FDA on SANA-013
AQ
03/14Wesana Health Holdings Announces Feedback from Pre-IND Meeting with Food and Drug Admin..
CI
03/11Wesana Provides Updates on Build-out of Third Clinic
AQ
03/11Wesana Provides Updates on Build-Out of Third Clinic
CI
01/25Wesana Health Holdings Appoints Meghna A. Gaeta as Chief Marketing Officer
CI
01/25Wesana Health Appoints Meghna A. Gaeta as Chief Marketing Officer
GL
01/18Wesana Health Announces Positive Findings From Animal Study on Novel Depression Treatme..
AQ
01/18Wesana Health Announces Positive Findings from Animal Study on Novel Depression Treatme..
CI
01/12Wesana Health Holdings Inc. Announces Executive Changes
CI
01/12Wesana Health Provides Strategic and Operational Updates
GL
01/12Wesana Health Holdings Inc. Announces Resignation of Israel Mirsky, Chief Marketing and..
CI
01/11Wesana Health Granted US FDA Pre-IND Meeting for SANA-013
GL
01/11Wesana Health Holdings Inc. Grants US FDA Pre-IND Meeting for SANA-013
CI
2021MAPS and Wesana Health Resume Negotiations
AQ
2021Wesana Health Holdings Inc. Files Patent Cooperation Treaty Patent Applications Towards..
CI
2021Wesana Completes Filing of PCT Patents for Novel Drug Protocols
GL
2021Wesana Health Reports Q3 2021 Financial Results
GL
2021Wesana Health Holdings Inc. acquired Advanced Psychiatric Management LLC.
CI
2021Wesana Health Clinics Crosses 4,000 Administered Ketamine Treatments
MT
2021Wesana Health Clinics Surpass 4,000 Administered Ketamine Treatments
AQ
2021KCSA Psychedelics Virtual Investor Conference Presentations Available for On-Demand Vie..
AQ
2021KCSA Psychedelics Virtual Investor Conference Agenda Announced for October 13th & 14th
AQ
2021WESANA HEALTH : Announces Inclusion in the AdvisorShares Psychedelics ETF
GL
2021WESANA HEALTH : Commits Funding of $1.5 Million To Support MAPS' Research Pipeline
AQ
2021Wesana Health Commits Funding of $1.5 Million To Support MAPS' Research Pipeline
GL
2021Wesana Health Holdings Inc. Announces Executive Changes
CI
2021WESANA HEALTH : Announces Closing of PsyTech Acquisition
AQ
2021Wesana Health Holdings Inc. completed the acquisition of PsyTech Inc.
CI
2021WESANA HEALTH : Distinguished Psychedelic Researcher, Professor of Psychiatry and Neurosci..
AQ
2021Wesana Health Holdings Inc. Appoints Rachel Yehuda, as Scientific Advisory Board
CI
2021WESANA HEALTH : Early Warning News Release
GL
2021Wesana Health Highlights Recent Appointments to Board of Directors
GL
2021Wesana Health Holdings Inc. Announces Board Appointments
CI
2021WESANA HEALTH : Commences Functional Animal Study for Treatment of Traumatic Brain Injury
AQ
2021WESANA HEALTH : Commences Functional Animal Study for Treatment of Traumatic Brain Injury
AQ
2021Wesana Health Commences Functional Animal Study for Treatment of Traumatic Brain Injury
CI
2021WESANA HEALTH : Announces listing on otcqb venture market
AQ
2021WESANA HEALTH : Ian Burnstein Joins Wesana Health Board of Directors
AQ
2021Wesana Health Holdings Inc. Appoints Ian Burnstein to its Board of Directors
CI
2021WESANA HEALTH : Psytech To Merge With Wesana; Mycotopia Shareholders Will Benefit From The..
AQ
2021WESANA HEALTH : Ian Burnstein Joins Wesana Health Advisory Board
AQ
2021Ian Burnstein Joins Advisory Board of Wesana Health Holdings Inc
CI
2021WESANA HEALTH : to Acquire PsyTech Inc. For $21 Million in All-Share Deal
MT
2021WESANA HEALTH : IIROC Trade Resumption - WESA
AQ
2021WESANA HEALTH : IIROC Trading Halt - WESA
AQ
2021Wesana Health Holdings Inc. entered into a definitive agreement to acquire PsyTech Inc...
CI
2021WESANA HEALTH : Partners with University of South Carolina
AQ
2021Wesana Health Holdings Inc. Announces A Partnership with the University of South Caroli..
CI
2021Wesana Health Holdings Inc. Appoints James Fadiman to Scientific Advisory Board
CI
2021Wesana Health Expands Research Leadership Team with Mark Wingertzahn as Chief Scientifi..
CI
2021WESANA HEALTH : The World Boxing Council and Wesana Health Announce Multi-Year Joint Effor..
AQ
2021The World Boxing Council and Wesana Health Holdings Inc. Announce Multi-Year Joint Effo..
CI
2021Wesana Health Holdings Inc. Appoints George Steinbrenner IV to its Board of Directors
CI
2021Made Therapeutics, Inc. announced that it has received $4.109 million in funding
CI
2021Made Therapeutics, Inc. announced that it expects to receive $4.109 million in funding
CI
2021Made Therapeutics, Inc. announced that it expects to receive CAD 15 million in funding
CI
1  2Next